SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: BD who wrote (690)1/9/1998 3:50:00 PM
From: James Silverman  Read Replies (1) | Respond to of 887
 
Brian-
The panel-whether rightly or wrongly-concluded that DepoCyt is at best comparable to MTX but at the cost of higher toxicity. So if approved it may well be next line treatment after MTX. In light of the above, and given the market for MTX for this particular indication is tiny, where will this leave DepoCyt?